title: Voriconazole stability in cement spacers.
authors.affiliation: Department of Infectious Diseases, University Hospital of Limoges, CHU Dupuytren, 2 avenue Martin-Luther-King, 87000 Limoges, France. e.denes@free.fr
authors.forename: E
authors.initials: E
authors.lastname: Denes
authors.forename: F
authors.initials: F
authors.lastname: Fiorenza
authors.forename: F
authors.initials: F
authors.lastname: Saint-Marcoux
authors.forename: M
authors.initials: M
authors.lastname: Megherbi
authors.forename: M
authors.initials: M
authors.lastname: Dupon
authors.forename: P
authors.initials: P
authors.lastname: Weinbreck
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D019644:Arthroplasty, Replacement, Hip; D018441:Biofilms / Q000187:drug effects; D001843:Bone Cements; D041221:Candida glabrata / Q000302:isolation & purification*; D002177:Candidiasis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D000077336:Caspofungin; D020878:Device Removal; D004305:Dose-Response Relationship, Drug; D004343:Drug Implants; D004355:Drug Stability; D004359:Drug Therapy, Combination; D054714:Echinocandins / Q000008:administration & dosage / Q000627:therapeutic use; D006622:Hip Prosthesis / Q000009:adverse effects* / Q000382:microbiology; D006801:Humans; D007262:Infusions, Intravenous; D055666:Lipopeptides; D008297:Male; D008875:Middle Aged; D019736:Prostheses and Implants; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000601:surgery; D011743:Pyrimidines / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D014230:Triazoles / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D001843:Bone Cements; D004343:Drug Implants; D054714:Echinocandins; D055666:Lipopeptides; D011743:Pyrimidines; D014230:Triazoles; D000077336:Caspofungin; D065819:Voriconazole